MERLINO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 6.215
AS - Asia 4.324
EU - Europa 2.163
SA - Sud America 734
AF - Africa 99
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 7
Totale 13.553
Nazione #
US - Stati Uniti d'America 6.089
SG - Singapore 2.293
CN - Cina 736
BR - Brasile 544
IT - Italia 453
UA - Ucraina 439
HK - Hong Kong 364
VN - Vietnam 336
DE - Germania 283
FI - Finlandia 211
RU - Federazione Russa 197
FR - Francia 189
BD - Bangladesh 178
IE - Irlanda 85
AR - Argentina 73
GB - Regno Unito 68
KR - Corea 66
IN - India 65
CA - Canada 61
SE - Svezia 46
NL - Olanda 43
IQ - Iraq 42
TR - Turchia 40
ZA - Sudafrica 36
ID - Indonesia 34
EC - Ecuador 30
MX - Messico 28
AT - Austria 27
PK - Pakistan 27
PL - Polonia 27
JP - Giappone 24
CO - Colombia 23
ES - Italia 21
UZ - Uzbekistan 19
VE - Venezuela 18
PY - Paraguay 16
BE - Belgio 15
SA - Arabia Saudita 15
MA - Marocco 13
CL - Cile 12
IR - Iran 12
PH - Filippine 12
TG - Togo 11
EG - Egitto 10
LT - Lituania 10
EU - Europa 9
PE - Perù 9
CZ - Repubblica Ceca 8
MY - Malesia 7
CH - Svizzera 6
CR - Costa Rica 6
JM - Giamaica 6
KE - Kenya 6
AU - Australia 5
AZ - Azerbaigian 5
DZ - Algeria 5
ET - Etiopia 5
HN - Honduras 5
IL - Israele 5
JO - Giordania 5
NP - Nepal 5
PS - Palestinian Territory 5
RS - Serbia 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AL - Albania 4
AM - Armenia 4
KG - Kirghizistan 4
RO - Romania 4
BH - Bahrain 3
BO - Bolivia 3
GR - Grecia 3
GT - Guatemala 3
KZ - Kazakistan 3
LV - Lettonia 3
PT - Portogallo 3
SN - Senegal 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BS - Bahamas 2
BZ - Belize 2
GA - Gabon 2
KH - Cambogia 2
LB - Libano 2
LI - Liechtenstein 2
LU - Lussemburgo 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
Totale 13.533
Città #
Singapore 854
Ashburn 542
Fairfield 463
Woodbridge 462
Ann Arbor 386
Hong Kong 350
San Jose 339
Beijing 331
Houston 309
Jacksonville 309
Chandler 284
Council Bluffs 208
Wilmington 203
Cambridge 167
Dearborn 164
Boardman 160
Seattle 152
Lauterbourg 129
Los Angeles 114
Ho Chi Minh City 108
Princeton 91
Dublin 83
Dallas 75
New York 74
Hanoi 71
São Paulo 64
Buffalo 62
Hefei 62
Seoul 62
Helsinki 51
Santa Clara 49
Redondo Beach 47
Munich 40
Frankfurt am Main 35
Milan 35
San Diego 32
Orem 29
Trieste 29
Udine 29
Ogden 28
Rome 28
Izmir 27
Venezia 26
Tavagnacco 25
Norwalk 24
Johannesburg 23
Nuremberg 23
The Dalles 23
Warsaw 23
Guangzhou 22
Tokyo 21
Chicago 20
Dong Ket 20
Ottawa 19
Phoenix 19
Atlanta 18
Buenos Aires 18
Rio de Janeiro 17
Stockholm 17
Amsterdam 16
Brooklyn 16
Denver 16
London 16
Tashkent 16
Des Moines 15
Boston 14
Da Nang 14
Düsseldorf 14
Brasília 13
Brussels 13
Codroipo 13
Mexico City 13
Montreal 13
Haiphong 12
Mumbai 12
Shanghai 12
Toronto 12
Vienna 12
Lomé 11
Nanjing 11
Quito 11
San Francisco 11
Baghdad 10
Kunming 10
Lappeenranta 10
Poplar 10
Hyderabad 9
Lahore 9
San Pietro Mussolino 9
Asunción 8
Biên Hòa 8
Bogotá 8
Bologna 8
Changsha 8
Secaucus 8
Shenzhen 8
Thái Nguyên 8
Turku 8
Chennai 7
Curitiba 7
Totale 7.954
Nome #
Restless legs syndrome: diagnosis, epidemiology, classification and consequences. 261
Restless legs syndrome: differential diagnosis and management with rotigotine 256
ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome 187
Clinical experience with pramipexole in the treatment of restless legs syndrome 179
Gabapentin Enacarbil in Restless Legs Syndrome 175
A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure 171
ADMET considerations for restless leg syndrome drug treatments. 165
Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures 165
The use of rotigotine in the treatment of restless legs syndrome. 162
Association of body rolling, leg rolling, and rhythmic feet movements in a young adult: A video-polysomnographic study performed before and after one night of clonazepam. 160
Anticholinergic drugs and neuropsychiatry symptoms in Alzheimer’s disease 156
Are sleep disorders able to increase cardiovascular risk in continuous ambulatory peritoneal dialysis (CAPD) patients ? 155
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 154
Opioids in the treatment of restless legs syndrome: pharmacological and clinical aspects 153
Timing use of novel anti-epileptic drugs: is earlier better? 148
Changes in hemodynamics during isoflurane and propofol anesthesia: a comparison study. 147
The Acute Effect of a Low Dosage of Pramipexole on Severe Idiopathic Restless Legs Syndrome: An Open-Label Trial. 147
Lacosamide for the treatment of epilepsy 146
Efficacy and Safety of Intravenous Thrombolysis in Patients with Acute Ischemic Stroke and Pre⁻Existing Disability 146
Investigational approaches to therapies for restless legs syndrome 142
Impact of atrial fibrillation on outcomes in stroke patients with tandem occlusions treated with thrombectomy: A multicentre study 139
Are sleep disorders able to Increase cardiovascular risk in chronic hemodialyzed patients (CHP) ? 138
Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease 138
Pharmacotherapy of restless legs syndrome with pramipexole 136
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. 136
Botulinum Toxin Type A for Trigeminal Neuralgia: A Comprehensive Literature Review 134
Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy 134
Predictors of futile recanalization after intravenous thrombolysis in stroke patients transferred for endovascular treatment 132
Non-REM hypnic headache: a circadian disorder? A clinical and polysomnographic study 127
Association between Restless Legs Syndrome and type 2 diabetes: a case control study. 127
Daytime Sleepiness is Associated with Dementia and Cognitive Decline in Older Italian Adults. A population-based study 126
Age-Specific Differences in Inflammatory Biomarkers and Their Impact on Futile Recanalization After Mechanical Thrombectomy: An Inverse Probability Weighting Analysis 125
The Prepetrous Segment of the Internal Carotid Artery as a Neglected Site of Symptomatic Atherosclerosis: A Single-Center Series 123
Brady Arrhythmia and sinus arrest in REM sleep 123
Restless legs syndrome in dialysis patients: a comparison between hemodialysis and continuous ambulatory peritoneal dialysis 122
Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient 121
Seizures with prolonged EEG abnormalities during an attack of migraine without aura. 121
Anti-neuropil antibodies in a patient with limbic encephalitis and breast cancer 117
­ Motor patterns of alien limb in different vigilance states: recording of periodic limb movement during wakefulness vs. sleep in a patient with Corticobasal degeneration (CBD) 115
Sleep-related movement disorders. 114
Incidence of early poststroke seizures during reperfusion therapies in patients with acute ischemic stroke: An observational prospective study: (TESI study: "Trombolisi/Trombectomia e crisi Epilettiche precoci nello Stroke Ischemico") 114
Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case Reports 114
Association between restless legs Syndrome and type 2 diabetes and consequences on quality of life and on psychological status: a case-control study 112
­Sleep fragmentation and cerebrovascular risk factors 112
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 110
2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study 109
Bereitshaftpotential and fatigue in recently diagnosed SM patients 108
Sensory gating deficit assessed by the P50 midlatency auditory evoked potential in untreated patients with Alzheimer’s Disease (AD): correlation with NeuroPsychiatric Symptoms (NPS) and modifications induced by the Cholinesterase Inhibitor (CHEI) done 108
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome 107
Event – Related Potential ERP) P300 in chronic vascular hemiparetic patients 107
Response to restless legs syndrome and diabetic neuropathy--commentary by Gemignani, et al 105
Insomnia and daytime sleepiness predict 20-year mortality in older male adults: data from a population-based study 105
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 104
Do sleep disorders start in dialysis or in early chronic kidney disease? Reply 104
­Alternating leg muscle activation (ALMA) with excessive daytime sleepiness 104
­Non-REM hypnic headache: a circadian disorder? A clinical and polysomnographic study 104
The impact of inflammatory markers on clinical outcomes in acute ischemic stroke patients following mechanical thrombectomy: A multicentre study 103
The Possible Precipitating Role of SARS-CoV-2 in a Case of Late-Onset Hemichorea Due to a Hyperosmolar Hyperglycemic State: Case Report and Brief Literature Review 103
Prevalence of “poor sleep” among patients with multiple sclerosis: An independent predictor of mental and physical status 102
Ketogenic diet may improve sleep quality and daytime somnolence in patients affected by multiple sclerosis. Results of an exploratory study 101
Prevalence of sleep disorders in patients with end-stage renal disease undergoing dialysis therapy 101
Prevalence and impact on quality of life of sleep disturbance among patients affected by multiple sclerosis. 101
Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer’s disease 101
The effect of drugs with anticholinergic activity on cognitive and neuropsychiatric symptoms in Alzheimer disease 100
When Nothing Goes Right: An Unexpected Tongue Deviation in Internal Carotid Artery Dissection 100
Seizures Do Not Affect Disability and Mortality Outcomes of Stroke: A Population-Based Study 100
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis 98
Restless legs syndrome in chronic hemodyalized patients: preliminary data 98
Sleep paralysis and hallucinations 98
Seizures after ischemic stroke: a matched multicenter study 98
La sindrome delle gambe senza riposo nel paziente nefropatico 97
Lower lymphocyte counts and older age are associated with reduced multiple sclerosis disease activity during dimethyl fumarate treatment 97
Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model 95
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome 95
. Ottimizzazione della terapia farmacologia con pregabalin in un paziente con epilessia ed alterazioni del sonno notturno (sindrome delle gambe senza riposo) 95
­Effetti acuti di basse dosi di pramipexolo in pazienti affetti da Sindrome delle gambe senza riposo severa idiopatica 94
­ Prevalence of “poor sleep” among patients with multiple sclerosis: an independent predictor of mental and physical status 94
Recanalisation theraphy for acute ischemic stroke in cancer patients 93
The use of alteplase, although safe, does not offer clear clinical advantages when mild stroke is non-disabling 92
To Treat or Not to Treat: Importance of Functional Dependence in Deciding Intravenous Thrombolysis of "Mild Stroke" Patients 91
Trattamento farmacologico della sindrome delle gambe senza riposo con farmaci non-dopaminoagonisti 89
Stress hyperglycemia is predictive of worse outcome in patients with acute ischemic stroke undergoing intravenous thrombolysis 89
Neuroinvasive west nile infection with an unusual clinical presentation: a single-center case series 88
Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference? 87
Short and long-term outcomes after combined intravenous thrombolysis and mechanical thrombectomy versus direct mechanical thrombectomy: a prospective single-center study 86
­Patologie ipofisarie e sonno 86
­The predictive value of mini-mental state examination as dementia screening tool in general medical practice 86
Stress Hyperglycemia in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion Undergoing Mechanical Thrombectomy 86
Effects of restless legs syndrome on quality of life ad psychological status in patients with type 2 diabetes 86
Stress Hyperglycemia Does Not Affect Clinical Outcome of Diabetic Patients Receiving Intravenous Thrombolysis for Acute Ischemic Stroke 85
­Sindrome delle gambe senza riposo: tra certezze e controversie 85
Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome 84
Prior Use of Antiplatelet Therapy and Outcomes after Endovascular Therapy in Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single-Center Experience 84
La sindrome delle gambe senza riposo nei pazienti emodializzati cronici 83
Sleep disturbances in dialysis patients 83
Sleep of migraine patients is ameliorated by ketogenic diet, independently of pain control 82
Restless leg syndrome in dalysis patients 82
­Disturbi del sonno in pazienti affetti da insufficienza renale cronica sottoposti a terapia dialitica 81
Filtro neurosensoriale e disturbi psichico-comportamentali nei malati di Alzheimer: studio in aperto con Donepezil 81
Dynamic Hyperglycemic Patterns Predict Adverse Outcomes in Patients with Acute Ischemic Stroke Undergoing Mechanical Thrombectomy 81
Totale 11.691
Categoria #
all - tutte 53.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.979


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022636 19 64 34 46 15 46 18 41 9 103 133 108
2022/2023696 97 39 17 74 74 207 3 44 70 7 30 34
2023/2024395 38 22 31 10 27 36 7 40 44 71 9 60
2024/20252.906 40 138 110 99 221 126 140 130 311 238 561 792
2025/20265.259 397 462 464 555 729 353 522 219 333 457 473 295
2026/2027168 168 0 0 0 0 0 0 0 0 0 0 0
Totale 13.919